Research Blog

Rockefeller University’s Elaine Fuchs, Ph.D., named 2016 recipient of the Vanderbilt Prize in Biomedical Science

Nov. 28, 2016—Elaine Fuchs, Ph.D., whose innovative use of reverse genetics has helped redefine the study of skin diseases and cancer stem cells, is the recipient of the 2016 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center (VUMC) announced today.

Nine Vanderbilt faculty members elected AAAS fellows

Nov. 25, 2016—Nine Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.

Graduate student’s cancer studies land NCI support

Nov. 17, 2016—Kamakoti “Kami” Bhat, a fifth-year graduate student in the lab of David Cortez, Ph.D., professor of Biochemistry in the School of Medicine, has achieved a “first” for Vanderbilt University.

VICC trial putting lung cancer therapy to the test

Oct. 20, 2016—Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis.

Lemonade Stand grant boosts Tansey’s pediatric tumor research

Sep. 1, 2016—William Tansey, Ph.D., professor of Cell Development and Biology and Ingram Professor of Cancer Research, has been awarded a two-year, $250,000 grant from Alex’s Lemonade Stand Foundation (ALSF) to study malignant rhabdoid tumors (MRTs).

Trial to test whether DBS slows Parkinson’s progression

Sep. 1, 2016—A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients.

Program helps Ph.D. students find non-academic careers

Aug. 18, 2016—In 2013, Vanderbilt University School of Medicine (VUSM) received one of 10 grants from the National Institutes of Health called BEST (Broadening Experiences in Scientific Training) to help train scientists for a variety of diverse careers.

Kleberg Foundation grant bolsters cancer drug discovery efforts

Aug. 3, 2016—The Robert J. Kleberg Jr. and Helen C. Kleberg Foundation has awarded a $3 million grant to Vanderbilt-Ingram Cancer Center (VICC) investigators in support of VICC’s drug discovery program. The gift awarded over the next three years from the private, San Antonio, Texas-based foundation will enable VICC researchers to pursue the development of new compounds to block the activity of cancer-causing genes and proteins that had previously been considered “undruggable.”

Award bolsters study of alcohol’s impact on the brain

Jul. 28, 2016—Vanderbilt University researcher Danny Winder, Ph.D., has received a MERIT Award from the National Institute of Alcohol Abuse and Addiction (NIAAA), part of the National Institutes of Health, for his contributions to understanding how alcohol affects the brain.

Seminar focuses on latest concussion research

Jul. 28, 2016—Neuropsychologist Gary Solomon, Ph.D., recently weighed in on one of the hottest debates in sports medicine, asserting that research doesn’t support the popular theory that concussions put athletes at higher risk for psychiatric illness.

Opioids’ impact on women’s health explored at research symposium

Jul. 28, 2016—Women may be at higher risk than men when it comes to overuse of opioid-containing painkillers, speakers warned at a research symposium at Vanderbilt University Medical Center earlier this month.